LESLIE ROSS: Open Payments
NPI 1447640669 · GLEN ROSE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 60 payments from 16 companies in 2025. Trend: 2023 $954 · 2024 $1,301 · 2025 $1,107
Food & beverage: $1,107
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $276 |
| ABBVIE INC. | 14 | $197 |
| Novo Nordisk Inc | 6 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Ardelyx, Inc. | 2 | $44 |
| Dexcom, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
Products named: EVENITY, VRAYLAR, Auvelity, REXULTI, AIRSUPRA, Wegovy, IBSRELA, QULIPTA.
Industry payments across TX — which companies pay providers there.
